메뉴 건너뛰기




Volumn 19, Issue 4, 2007, Pages 340-345

Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis

Author keywords

Ankylosing spondylitis; Bisphosphonates; Bone involvement

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CYTOKINE; ETIDRONIC ACID; IBANDRONIC ACID; LIPOSOME; METHOTREXATE; PAMIDRONIC ACID; PLACEBO; RISEDRONIC ACID; TILUDRONIC ACID; ZOLEDRONIC ACID;

EID: 34249995446     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328133f57b     Document Type: Review
Times cited : (50)

References (36)
  • 1
    • 0037029430 scopus 로고    scopus 로고
    • Treatment of active ankylosing spondylitis with infliximab: A randomized controlled multicentre trial
    • Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002; 359:1187-1193.
    • (2002) Lancet , vol.359 , pp. 1187-1193
    • Braun, J.1    Brandt, J.2    Listing, J.3
  • 2
    • 0242411795 scopus 로고    scopus 로고
    • Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
    • Davis JC, Van Der Heijde D, Braun J, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003; 48:3230-3236.
    • (2003) Arthritis Rheum , vol.48 , pp. 3230-3236
    • Davis, J.C.1    Van Der Heijde, D.2    Braun, J.3
  • 3
    • 0042887352 scopus 로고    scopus 로고
    • Systematic safety follow up in a cohort of 107 patients with spondylarthropathy treated with infliximab: A new perspective on the role of host defence in the pathogenesis of the disease?
    • Baeten D, Kruithof E, Van Den Bosch F, et al. Systematic safety follow up in a cohort of 107 patients with spondylarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 2003; 62:829-834.
    • (2003) Ann Rheum Dis , vol.62 , pp. 829-834
    • Baeten, D.1    Kruithof, E.2    Van Den Bosch, F.3
  • 5
    • 0031977199 scopus 로고    scopus 로고
    • Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras
    • Luckman SP, Hughes DE, Coxon FP, et al. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998; 13:581-589.
    • (1998) J Bone Miner Res , vol.13 , pp. 581-589
    • Luckman, S.P.1    Hughes, D.E.2    Coxon, F.P.3
  • 7
    • 0037333411 scopus 로고    scopus 로고
    • Bisphosphonates for arthritis: A confusing rationale
    • Maksymowych WP. Bisphosphonates for arthritis: a confusing rationale. J Rheumatol 2003; 30:430-434.
    • (2003) J Rheumatol , vol.30 , pp. 430-434
    • Maksymowych, W.P.1
  • 8
    • 0024544443 scopus 로고
    • Clinical, biochemical and radiological effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis
    • Ralston SH, Hacking L, Willocks L, et al. Clinical, biochemical and radiological effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis. Ann Rheum Dis 1989; 48:396-399.
    • (1989) Ann Rheum Dis , vol.48 , pp. 396-399
    • Ralston, S.H.1    Hacking, L.2    Willocks, L.3
  • 9
    • 0032703282 scopus 로고    scopus 로고
    • Evaluation of bone turn over and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate
    • Cantatore FP, Acquista CA, Pipitone V. Evaluation of bone turn over and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 1999; 26:2318-2323.
    • (1999) J Rheumatol , vol.26 , pp. 2318-2323
    • Cantatore, F.P.1    Acquista, C.A.2    Pipitone, V.3
  • 10
    • 0037333914 scopus 로고    scopus 로고
    • Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis
    • Hasegawa J, Nagashima M, Yamamoto M, et al. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. J Rheumatol 2003; 30:474-479.
    • (2003) J Rheumatol , vol.30 , pp. 474-479
    • Hasegawa, J.1    Nagashima, M.2    Yamamoto, M.3
  • 11
    • 33646484359 scopus 로고    scopus 로고
    • Preliminary evidence for a structural benefit of the new bisphosphonate zolendronic acid in early rheumatoid arthritis
    • Demonstration of a structural effect of the amino bisphosphonate zoledronic acid in patients with early RA
    • Jarrett S, O'Connor P, Conaghan P, et al. Preliminary evidence for a structural benefit of the new bisphosphonate zolendronic acid in early rheumatoid arthritis. Arthritis Rheum 2006; 54:1410-1414. Demonstration of a structural effect of the amino bisphosphonate zoledronic acid in patients with early RA.
    • (2006) Arthritis Rheum , vol.54 , pp. 1410-1414
    • Jarrett, S.1    O'Connor, P.2    Conaghan, P.3
  • 12
    • 0028842688 scopus 로고
    • Inhibition of antigen-presenting cell function by alendronate in vitro
    • Sansoni P, Passeri G, Fagnoni F, et al. Inhibition of antigen-presenting cell function by alendronate in vitro. J Bone Miner Res 1995; 10:1719-1725.
    • (1995) J Bone Miner Res , vol.10 , pp. 1719-1725
    • Sansoni, P.1    Passeri, G.2    Fagnoni, F.3
  • 13
    • 0029056655 scopus 로고
    • Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNFalpha secretion from RAW 264 cells in vitro
    • Pennanen N, Lapinjoki S, Urtti A, et al. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNFalpha secretion from RAW 264 cells in vitro. Pharm Res 1995; 12:916-922.
    • (1995) Pharm Res , vol.12 , pp. 916-922
    • Pennanen, N.1    Lapinjoki, S.2    Urtti, A.3
  • 14
    • 0032535988 scopus 로고    scopus 로고
    • Effects of tiludronate and ibandronate on the secretion of pro-inflammatory cytokines and nitric oxide from macrophages in vitro
    • Monkkonen J, Simila J, Rogers MJ. Effects of tiludronate and ibandronate on the secretion of pro-inflammatory cytokines and nitric oxide from macrophages in vitro. Life Sci 1996; 62:95-102.
    • (1996) Life Sci , vol.62 , pp. 95-102
    • Monkkonen, J.1    Simila, J.2    Rogers, M.J.3
  • 15
    • 0029053245 scopus 로고
    • Effect of clodronate on established collagen induced arthritis in rats
    • Osterman T, Kippo K, Lauren L, et al. Effect of clodronate on established collagen induced arthritis in rats. Inflamm Res 1995; 44:258-263.
    • (1995) Inflamm Res , vol.44 , pp. 258-263
    • Osterman, T.1    Kippo, K.2    Lauren, L.3
  • 16
    • 0036185343 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
    • Redlich K, Hayer S, Maier A, et al. Tumor necrosis factor alpha mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 2002; 46:785-792.
    • (2002) Arthritis Rheum , vol.46 , pp. 785-792
    • Redlich, K.1    Hayer, S.2    Maier, A.3
  • 17
    • 3142741595 scopus 로고    scopus 로고
    • Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis
    • Herrak P, Görtz B, Hayer S, et al. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis. Arthritis Rheum 2004; 50:2227-2237.
    • (2004) Arthritis Rheum , vol.50 , pp. 2227-2237
    • Herrak, P.1    Görtz, B.2    Hayer, S.3
  • 18
    • 3142763806 scopus 로고    scopus 로고
    • Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis
    • Sims NA, Green JR, Glatt M, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum 2004; 50:2238-2346.
    • (2004) Arthritis Rheum , vol.50 , pp. 2238-2346
    • Sims, N.A.1    Green, J.R.2    Glatt, M.3
  • 19
    • 0036402078 scopus 로고    scopus 로고
    • Bisphosphonates: Targeting bone in the treatment of spondyloarthritis
    • Haibel H, Braun J, Maksymowych WP. Bisphosphonates: targeting bone in the treatment of spondyloarthritis. Clin Exp Rheumatol 2002; 20 (Suppl 28): S162-S166.
    • (2002) Clin Exp Rheumatol , vol.20 , Issue.SUPPL. 28
    • Haibel, H.1    Braun, J.2    Maksymowych, W.P.3
  • 20
    • 0033694989 scopus 로고    scopus 로고
    • Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis
    • Francois RJ, Gardner DL, Degrave EJ, et al. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 2000; 43:2011-2024.
    • (2000) Arthritis Rheum , vol.43 , pp. 2011-2024
    • Francois, R.J.1    Gardner, D.L.2    Degrave, E.J.3
  • 21
    • 0035069607 scopus 로고    scopus 로고
    • Immunohistological study of entheses in spondylarthropathies: Comparison in rheumatoid arthritis and osteoarthritis
    • Laloux L, Voisin MC, Allain J, et al. Immunohistological study of entheses in spondylarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2001; 60:316-321.
    • (2001) Ann Rheum Dis , vol.60 , pp. 316-321
    • Laloux, L.1    Voisin, M.C.2    Allain, J.3
  • 22
    • 33744486334 scopus 로고    scopus 로고
    • Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: Detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases
    • An histopathological study of sacroiliac joints from patients with ankylosing spondylitis showing the presence of macrophages in the bone marrow area
    • Francois RJ, Neure L, Sieper J, et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006; 65:713-720. An histopathological study of sacroiliac joints from patients with ankylosing spondylitis showing the presence of macrophages in the bone marrow area.
    • (2006) Ann Rheum Dis , vol.65 , pp. 713-720
    • Francois, R.J.1    Neure, L.2    Sieper, J.3
  • 23
    • 34250026855 scopus 로고    scopus 로고
    • Braun J, Baraliakos X, Zelder C, et al. Clinical and histopathological findings in patients with ankylosing spondylitis before and after surgical treatment for axis correction and erection of the spine. Arthritis Rheum 2006; 54 (Suppl):S466. [abstract].
    • Braun J, Baraliakos X, Zelder C, et al. Clinical and histopathological findings in patients with ankylosing spondylitis before and after surgical treatment for axis correction and erection of the spine. Arthritis Rheum 2006; 54 (Suppl):S466. [abstract].
  • 24
    • 0028358338 scopus 로고
    • Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients
    • Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994; 37:1039-1045.
    • (1994) Arthritis Rheum , vol.37 , pp. 1039-1045
    • Braun, J.1    Bollow, M.2    Eggens, U.3
  • 25
    • 0036403023 scopus 로고    scopus 로고
    • Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides
    • Bollow M, Enzweiler C, Taupitz M, et al. Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. Clin Exp Rheumatol 2002; 20 (Suppl 28):S167-S174.
    • (2002) Clin Exp Rheumatol , vol.20 , Issue.SUPPL. 28
    • Bollow, M.1    Enzweiler, C.2    Taupitz, M.3
  • 26
    • 0033777172 scopus 로고    scopus 로고
    • Bone mass in ankylosing spondylitis
    • Toussirot E, Wendling D. Bone mass in ankylosing spondylitis. Clin Exp Rheumatol 2000; 18 (Suppl 21):S16-S20.
    • (2000) Clin Exp Rheumatol , vol.18 , Issue.SUPPL. 21
    • Toussirot, E.1    Wendling, D.2
  • 27
    • 34249990530 scopus 로고    scopus 로고
    • Toussirot E, Dumoulin G, Nguyen NU, et al. Changes in bone cell enzymatic activities in ankylosing spondylitis and relationship with the inflammatory process. Arthritis Rheum 2006; 54 (Suppl):S466. [abstract].
    • Toussirot E, Dumoulin G, Nguyen NU, et al. Changes in bone cell enzymatic activities in ankylosing spondylitis and relationship with the inflammatory process. Arthritis Rheum 2006; 54 (Suppl):S466. [abstract].
  • 28
    • 12744281260 scopus 로고    scopus 로고
    • Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies
    • Toussirot E, Wendling D. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies. Expert Opin Pharmacother 2005; 6:35-43.
    • (2005) Expert Opin Pharmacother , vol.6 , pp. 35-43
    • Toussirot, E.1    Wendling, D.2
  • 29
    • 0031899867 scopus 로고    scopus 로고
    • An open study ofpamidronate in the treatment of refractory ankylosing spondylitis
    • Maksymowych WP, Jhangri GS, Leclercq S, et al. An open study ofpamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 1998; 25:714-717.
    • (1998) J Rheumatol , vol.25 , pp. 714-717
    • Maksymowych, W.P.1    Jhangri, G.S.2    Leclercq, S.3
  • 30
    • 0035171329 scopus 로고    scopus 로고
    • Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy
    • Maksymowych WP, Lambert R, Jhangri GS, et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 2001; 28:144-155.
    • (2001) J Rheumatol , vol.28 , pp. 144-155
    • Maksymowych, W.P.1    Lambert, R.2    Jhangri, G.S.3
  • 31
    • 0038423037 scopus 로고    scopus 로고
    • Treatment of active ankylosing spondylitis with pamidronate
    • Haibel H, Brandt J, Rudwaleit M, et al. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology 2003; 42:1018-1020.
    • (2003) Rheumatology , vol.42 , pp. 1018-1020
    • Haibel, H.1    Brandt, J.2    Rudwaleit, M.3
  • 32
    • 13244276402 scopus 로고    scopus 로고
    • An open study of pulse pamidronate treatment in severe ankylosing spondylitis and its effect on biochemical markers of bone turnover
    • Cairns AP, Wright SA, Taggart AJ, et al. An open study of pulse pamidronate treatment in severe ankylosing spondylitis and its effect on biochemical markers of bone turnover. Ann Rheum Dis 2005; 64:338-339.
    • (2005) Ann Rheum Dis , vol.64 , pp. 338-339
    • Cairns, A.P.1    Wright, S.A.2    Taggart, A.J.3
  • 33
    • 33646243798 scopus 로고    scopus 로고
    • Treatment of ankylosing spondylitis with pamidronate: An open label study
    • Grover R, Shankar S, Aneja R, et al. Treatment of ankylosing spondylitis with pamidronate: an open label study. Ann Rheum Dis 2006; 65:688-689.
    • (2006) Ann Rheum Dis , vol.65 , pp. 688-689
    • Grover, R.1    Shankar, S.2    Aneja, R.3
  • 34
    • 33746599375 scopus 로고    scopus 로고
    • Transient efficacy of pulse pamidronate in active spondylarthropathies: An open study of 35 cases
    • Toussirot E, Le Huédé G, Lohse A, et al. Transient efficacy of pulse pamidronate in active spondylarthropathies: an open study of 35 cases. Clin Exp Rheumatol 2006; 24:348.
    • (2006) Clin Exp Rheumatol , vol.24 , pp. 348
    • Toussirot, E.1    Le Huédé, G.2    Lohse, A.3
  • 35
    • 0036188770 scopus 로고    scopus 로고
    • A six-month randomized, controlled, double-blind, dose response comparison of intravenous pamidronate (60mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis
    • Maksymowych WP, Jhangri GS, Fitzgerald AA, et al. A six-month randomized, controlled, double-blind, dose response comparison of intravenous pamidronate (60mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 2002; 46:766-773.
    • (2002) Arthritis Rheum , vol.46 , pp. 766-773
    • Maksymowych, W.P.1    Jhangri, G.S.2    Fitzgerald, A.A.3
  • 36
    • 2442417681 scopus 로고    scopus 로고
    • SAPHO syndrome treated with pamidronate: An open label study of 10 patients
    • Amital H, Applbaum YH, Aamar S, et al. SAPHO syndrome treated with pamidronate: an open label study of 10 patients. Rheumatology 2004; 43:658-661.
    • (2004) Rheumatology , vol.43 , pp. 658-661
    • Amital, H.1    Applbaum, Y.H.2    Aamar, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.